Mars Incorporated and Digitalis Ventures have announced the launch of Companion Fund II. This US$300 million dollar venture capital fund will back founders whose companies are leveraging breakthrough science, technology and design to improve the lives of pets, pet owners and veterinarians. This second fund follows the first Companion Fund, a US$100m fund launched in 2018.
Loïc Moutault, Global President of Mars Petcare, said that Mars’ goal was to support pet care founders, accelerate the trajectory of startups, help fuel the growth of pet care businesses and contribute to the future of the pet care industry.
“We're excited to support entrepreneurs and innovators in creating new products and services that deliver on our purpose: 'A Better World for Pets.'"
Companion Fund II will provide venture capital to various enterprises developing veterinary diagnostics, veterinary medicine, information technologies, online platforms and more. The new fund will be independently managed by Digitalis Ventures, focusing on both early and growth-stage startups with an ambition to support portfolio companies with differentiated expertise throughout their development while allowing them to maintain their independence, speed, and flexibility.
“With our second Companion Fund, we are eager to support the next wave of great ideas for advancing animal health at scale," said Geoffrey W. Smith, Founder and Managing Partner of Digitalis Ventures.
"Our partnership with Mars makes these advances possible.”
Since its inception, Companion Fund has quickly become one of the world's leading investment funds for early-stage pet care start-ups, with investments in innovative companies. The Companion Fund II will support even more startups through their growth phases, confirming Mars’ ongoing commitment to support pet care innovators and its long-term partnership with Digitalis Ventures.
Plans are for the Fund to invest in animal health companies based primarily in the United States and Europe.
